Healthcare-Acquired Infections (HAIs) are becoming increasingly common. Due to an increase in invasive procedures and a growing resistance to antibiotics, HAIs have increased by 36% in the last 20 years. The human cost is over 99,000 deaths per year, which represent a 5% death rate for HAIs. On average HAIs add an additional 8 days in the ICU and increases hospital stays for 9 days.
HAIs in hospitals alone result in an estimated $28- $33 billion in excess medical costs every year. That is an estimated cost of up to $32,000 per licensed bed in the U.S. For an average 180 bed facility, that equals an additional $5,760,000 in direct cost. Under the new Affordable Care Act (ACA), Hospitals will lose reimbursement based on a criteria that is heavily weighted on HAIs and patient satisfaction.
A microbial organism with
the ability to cause disease.
A person who cannot resist a microorganism invading the body, multiplying, and resulting in infection.
An opening allowing
to enter the host.
Method of transfer that the organism moves from one place to another.
A place of exit providing
a way for a microorganism
to leave the reservoir.
A place within which
thrive and reproduce.
The healthcare industry is challenged with providing the best possible care for their patients and a safe environment for health care workers. Micro-organisms are the most prevalent and potent pollutants in the indoor environment and their role as causers and aggravators of disease conditions are well documented.
Healthcare facilities, by the very nature of their operation, expose patients and staff to microbial contamination that can lead to infectious disease. Stethoscopes, flooring, doorknobs, curtains, cabinets and the "forgotten" surfaces can potentially transfer contaminating organisms from surface to surface and person to person.
MicrobeCare™ treatment is based on a unique antimicrobial technology which is odorless, colorless, NON-LEACHING, long-lasting and effectively controls bacteria, fungi, algae and yeast. Because it does not dissipate, it retains its full antimicrobial strength for the life of the surface to which it is applied. It controls mircro-organisms, slows the degredation of products, and reduces odors and stains.
will enable you to improve patient outcomes and lower your operating cost.
We start by testing
and verification of the Adenosine Triphosphate (ATP) levels on your equipment.
Then we use our newly
called MicrobeCare™ that
bonds to equipment
surfaces and lowers
The unique bonding properties make it
different than any other antimicrobials available.
Then we apply our unique software, Bac–Track, that monitors these levels on an easy to read dashboard dedicated to your facility. It also allows you to monitor by department or equipment category to pinpoint your problem areas.
After our initial reading with an Adensoine Triphosphate (ATP) meter, we will treat the equipment with a patented EPA-approved solution called MicrobeCare™. This formula reduces the amount of bacteria and viruses on your equipment. This breakthrough was proven effective for one year with only one application.
MicrobeCare™ is not designed to replace any of your current cleaning procedures.
The ATP monitor will provide a good benchmark of how effective your current procedures are.
By adding MicrobeCare™, your bacteria and virus levels will dramatically decrease, making it a safer environment for your caregivers and patients. This could reduce the chances of cross contamination and healthcare acquired infections related to contaminated equipment.
Bac-track is the first software that gives your facility a dashboard to monitor bacteria levels by department or equipment category. In addition, the software allows you to monitor monthly trends and treatment or cleaning effectiveness. Knowing this valuable information will enable you to pinpoint where the highest risk areas are for contamination.
A DIVISION OF